Literature DB >> 11003992

Renal blood flow, early distal sodium, and plasma renin concentrations during osmotic diuresis.

P P Leyssac1, N H Holstein-Rathlou, O Skøtt.   

Abstract

Inconsistencies in previous reports regarding changes in early distal NaCl concentration (ED(NaCl)) and renin secretion during osmotic diuresis motivated our reinvestigation. After intravenous infusion of 10% mannitol, ED(NaCl) fell from 42.6 to 34.2 mM. Proximal tubular pressure increased by 12.6 mmHg. Urine flow increased 10-fold, and sodium excretion increased by 177%. Plasma renin concentration (PRC) increased by 58%. Renal blood flow and glomerular filtration rate decreased, however end-proximal flow remained unchanged. After a similar volume of hypotonic glucose (152 mM), ED(NaCl) increased by 3.6 mM, (P < 0.01) without changes in renal hemodynamics, urine flow, sodium excretion rate, or PRC. Infusion of 300 micromol NaCl in a smaller volume caused ED(NaCl) to increase by 6.4 mM without significant changes in PRC. Urine flow and sodium excretion increased significantly. There was a significant inverse relationship between superficial nephron ED(NaCl) and PRC. We conclude that ED(Na) decreases during osmotic diuresis, suggesting that the increase in PRC was mediated by the macula densa. The results suggest that the natriuresis during osmotic diuresis is a result of impaired sodium reabsorption in distal tubules and collecting ducts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003992     DOI: 10.1152/ajpregu.2000.279.4.R1268

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

Review 1.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 2.  Tubular reabsorption and diabetes-induced glomerular hyperfiltration.

Authors:  P Persson; P Hansell; F Palm
Journal:  Acta Physiol (Oxf)       Date:  2010-05-27       Impact factor: 6.311

3.  Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Lisa M Harrison-Bernard; Hiroyuki Kobori; Yuri Ozawa; Kathleen S Hering-Smith; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2004-06-28       Impact factor: 10.190

Review 4.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

5.  Mannitol Reduces the Hydrostatic Pressure in the Proximal Tubule of the Isolated Blood-Perfused Rabbit Kidney during Hypoxic Stress and Improves Its Function.

Authors:  Robbert Bipat; Paul Steels; Yves Cuypers; Jerry R Toelsie
Journal:  Nephron Extra       Date:  2011-11-04

6.  SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM).

Authors:  Antonio Orlacchio; Carlo Guastoni; Giordano Domenico Beretta; Laura Cosmai; Michele Galluzzo; Stefania Gori; Emanuele Grassedonio; Lorena Incorvaia; Carmelita Marcantoni; Giuseppe Stefano Netti; Matteo Passamonti; Camillo Porta; Giuseppe Procopio; Mimma Rizzo; Silvia Roma; Laura Romanini; Fulvio Stacul; Alice Casinelli
Journal:  Radiol Med       Date:  2022-03-18       Impact factor: 6.313

7.  Contrast induced nephropathy in urology.

Authors:  Viji Samuel Thomson; Kumar Narayanan; J Chandra Singh
Journal:  Indian J Urol       Date:  2009 Oct-Dec

8.  Contrast Induced Nephropathy with Intravenous Iodinated Contrast Media in Routine Diagnostic Imaging: An Initial Experience in a Tertiary Care Hospital.

Authors:  Shuchi Bhatt; Nipun Rajpal; Vineeta Rathi; Rajneesh Avasthi
Journal:  Radiol Res Pract       Date:  2016-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.